Vaccine News and Research

Latest Vaccine News and Research

Department of Health offers statewide H1N1 vaccination; urges all Pennsylvanians to get vaccinated

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 4,003,100 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

29 Dec 2009

Selected store locations in Massachusetts, Virginia and California to receive H1N1 flu vaccinations

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Massachusetts, Virginia and Orange County, California beginning Tuesday, December 29.

29 Dec 2009

Promising results from Soligenix' RiVax vaccine against ricin toxin

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant regions of ricin A chain, the antigenic component of RiVax((TM)). RiVax((TM)) is Soligenix's vaccine to protect against exposure to ricin toxin and is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as nonhuman primate trials for efficacy.

29 Dec 2009

SVA submits the first clinical trial application for HFMD vaccine in China

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has filed the application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD). This is the first clinical trial application for HFMD vaccine submitted in China.

28 Dec 2009

Senate health care bill will increase patient access and help create high-wage, high-value jobs

“These provisions mean increased access for the patients of today and renewed hope for the patients of tomorrow. In addition, they will help create high-wage, high-value jobs in our nation’s burgeoning biotech sector and help maintain U.S. global leadership in innovation.”

28 Dec 2009

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

Earlier this year, researchers showed that they could cut the lives of disease-carrying mosquitoes in half by infecting them with a bacterium they took from fruit flies. Now, a new report in the December 24th issue of Cell, a Cell Press publication, suggests that their strategy might do one better: The Wolbachia bacteria also makes the mosquitoes more resistant to infection by viruses that are a growing threat to humans, including those responsible for dengue fever and Chikungunya.

28 Dec 2009

CtIP protein plays a critical role in DNA repair

La Jolla, CA-In order to preserve our DNA, cells have developed an intricate system for monitoring and repairing DNA damage. Yet precisely how the initial damage signal is converted into a repair response remains unclear. Researchers at the Salk Institute for Biological Studies have now solved a crucial piece of the complex puzzle.

28 Dec 2009

Findings may shed light on the origins of autism and attention deficit disorders

Like a spotlight that illuminates an otherwise dark scene, attention brings to mind specific details of our environment while shutting others out. A new study by researchers at the Salk Institute for Biological Studies shows that the superior colliculus, a brain structure that primarily had been known for its role in the control of eye and head movements, is crucial for moving the mind's spotlight.

28 Dec 2009

Opinion: Food aid; HIV vaccine, microbicide research; Global Tobacco Surveillance

In a Washington Post letter to the editor, Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, and Rafi Ahmed, science committee chairman of the Global HIV Vaccine Enterprise, challenge a recent Washington Post editorial that questioned the scientific progress being made in the search for an HIV vaccine and microbicide. "The search for a safe and effective method to prevent HIV infection and AIDS is a long journey in which we should expect both success and failure," the authors write, before highlighting the lessons learned from the recent microbicide gel study and AIDS vaccine trial in Thailand.

27 Dec 2009

New series of 30-second PSAs on getting vaccinated against H1N1 flu

The U.S. Department of Health and Human Services (HHS), in conjunction with the Ad Council and the Jim Henson Company, has released a new series of 30-second public service announcements (PSAs) about the importance of getting the 2009 H1N1 vaccine. Targeted to parents and children, the PSA campaign features 15 governors, a state first lady, a state chief medical officer and the main character from the PBS’ series “Sid the Science Kid” and reminds the public that getting vaccinated is the best way to stay healthy during this flu season.

24 Dec 2009

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care provider in the U.S., announced today an expanded H1N1 vaccine outreach effort.

24 Dec 2009

Walgreens offers H1N1 vaccinations throughout Indiana

Walgreens, the nation’s largest drugstore chain and industry leader with more than 17,000 certified or licensed immunizers, is now offering H1N1 vaccinations at all of its pharmacies throughout Indiana.

24 Dec 2009

More H1N1 vaccines available in U.S., many Americans don't want it

While an increasing number of H1N1 (swine flu) vaccines are available in the U.S., "more than half of American adults say they still don't want it, and one-third of parents say they don't want their children to get it either, according to two surveys," the Washington Post reports. "As of this week, 111 million doses of vaccine against the pandemic strain of H1N1 flu have been released to states and cities.

24 Dec 2009

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

24 Dec 2009

Majority of Australians think H1N1 vaccination is not necessary

Australia risks a serious swine flu (H1N1 influenza virus) outbreak with two-thirds (65 per cent) of unprotected Australians stating they're unlikely to get vaccinated against the disease in the next 12 months, according to an MBF Healthwatch Poll.

23 Dec 2009

Tripep’s rights offering oversubscribed

The preliminary result from Tripep’s rights offering shows that it has been oversubscribed with significant marginal (approximately 150%). Through the offering Tripep will receive approximately 17.8 MSEK before emission costs. The final outcome of the emission will be presented around the 30th of December 2009.

23 Dec 2009

One-third of parents do not expect to get H1N1 vaccine for kids; concerns about safety remains major factor

A new poll by researchers at the Harvard School of Public Health (HSPH) shows the shortage of H1N1 vaccine for children is easing. As of late last week, three-quarters of parents who tried to get the vaccine for their children were able to do so.

23 Dec 2009

Autism study and gene therapy in vision are top scientific achievements in 2009

A landmark autism study and a dramatic success for gene therapy in reversing inherited blindness, both at The Children's Hospital of Philadelphia, were recognized among the top scientific achievements in 2009, according to three national publications: Time magazine, Discover magazine and the journal Science.

23 Dec 2009

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.

23 Dec 2009

Staphylococcus aureus causes far more serious infections than previously realised

Staphylococcus aureus causes far more serious infections than previously realised, with more than 3,000 Swedes affected every year, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

23 Dec 2009

Vaccine News and Research

Latest Vaccine News and Research

Department of Health offers statewide H1N1 vaccination; urges all Pennsylvanians to get vaccinated

Selected store locations in Massachusetts, Virginia and California to receive H1N1 flu vaccinations

Promising results from Soligenix' RiVax vaccine against ricin toxin

SVA submits the first clinical trial application for HFMD vaccine in China

Senate health care bill will increase patient access and help create high-wage, high-value jobs

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

CtIP protein plays a critical role in DNA repair

Findings may shed light on the origins of autism and attention deficit disorders

Opinion: Food aid; HIV vaccine, microbicide research; Global Tobacco Surveillance

New series of 30-second PSAs on getting vaccinated against H1N1 flu

CVS/pharmacy and MinuteClinic expand H1N1 vaccine outreach effort

Walgreens offers H1N1 vaccinations throughout Indiana

More H1N1 vaccines available in U.S., many Americans don't want it

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

Majority of Australians think H1N1 vaccination is not necessary

Tripep’s rights offering oversubscribed

One-third of parents do not expect to get H1N1 vaccine for kids; concerns about safety remains major factor

Autism study and gene therapy in vision are top scientific achievements in 2009

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

Staphylococcus aureus causes far more serious infections than previously realised

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in